Search clinical trials for: Multiple Dosage
Total 14552 results
-
Peking University People's HospitalXingtai People's Hospital; Hebei Provincial People's HospitalNot yet recruiting
-
Xi'an Xintong Pharmaceutical Research Co.,Ltd.RecruitingChronic Hepatitis bChina
-
Soren OvergaardOdense University Hospital; Aarhus University Hospital; University of Copenhagen and other collaboratorsRecruitingTotal Hip Arthroplasty | Prosthetic-joint Infection | Fracture of Hip | Fracture AcetabularDenmark
-
Soren OvergaardOdense University Hospital; Aarhus University Hospital; University of Copenhagen and other collaboratorsRecruitingOsteoarthritis, Hip | Total Hip Arthroplasty | Prosthetic-joint InfectionDenmark
-
Amsterdam UMC, location VUmcRecruitingMultiple Sclerosis, Relapsing-RemittingNetherlands
-
University Hospital, MontpellierRecruitingAromatic L-Amino Acid Decarboxylase DeficiencyFrance
-
Francis CorazzaRecruitingMultiple SclerosisBelgium
-
University Hospital, ToulouseRecruitingEpilepsy | Prader-Willi Syndrome | Angelman Syndrome | Smith-Magenis Syndrome | X Fragile SyndromeFrance
-
Medical University InnsbruckUniversity Hospital, Bonn; Universitätsklinikum LeipzigRecruiting
-
Berkovich, Regina MD, PhD Inc.Biogen; Cedars-Sinai Medical CenterRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
National University Hospital, SingaporeNational University of SingaporeRecruiting
-
University of LeedsTakeda; Cancer Research UK; CelgeneRecruitingMultiple MyelomaUnited Kingdom
-
University of WashingtonRecruitingRefractory Multiple Myeloma | Plasma Cell Leukemia | Recurrent Multiple MyelomaUnited States
-
PfizerBiohaven Pharmaceutical Holding Company Ltd.Active, not recruitingMigraineSpain, United States, France, Canada, Germany, United Kingdom, Poland, Austria, Sweden, Italy
-
Abdullah KhanTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Taiwan, Poland, Thailand, Germany, France, Ireland, Greece, Korea, Republic of, United Kingdom, Australia, Italy, India, Argentina, Canada, Spain, Switzerland, Brazil, Mexico
-
Assistance Publique - Hôpitaux de ParisCompletedHypohidrotic Ectodermal DysplasiaFrance
-
Assistance Publique - Hôpitaux de ParisQIAGEN Gaithersburg, IncActive, not recruiting
-
Hadassah Medical OrganizationCompleted
-
Mayo ClinicActive, not recruitingPlasma Cell Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Smoldering Plasma Cell MyelomaUnited States
-
EnteromeCovanceActive, not recruitingGlioblastoma, AdultUnited States, Spain, France, Germany
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingIdasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaRecurrent Plasma Cell Myeloma | Loss of Chromosome 17pUnited States
-
Adaptive BiotechnologiesActive, not recruitingMultiple Myeloma | Chronic Lymphocytic Leukemia | Non-hodgkin Lymphoma | Acute Lymphoblastic Leukemia, Adult B-CellUnited States
-
Amsterdam UMC, location VUmcInnovatiefonds Zorgverzekeraars; Stichting MS Research; Stichting TreatmedsEnrolling by invitationRelapsing Remitting Multiple SclerosisNetherlands
-
University of WashingtonNational Cancer Institute (NCI); SecuraBioTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Stony Brook UniversityActive, not recruitingParkinson Disease | Multiple System Atrophy | Normal Pressure Hydrocephalus | Rapid Eye Movement Sleep Behavior DisorderUnited States
-
Norwegian University of Science and TechnologyOslo University Hospital; St. Olavs HospitalCompleted
-
University Hospital, CaenBiogenCompletedMultiple Sclerosis, Relapsing-RemittingFrance
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States, Czechia, France, Spain, Japan, Germany, Italy, Brazil, Denmark, Austria, United Kingdom, China, Russian Federation, Mexico, Poland, Ukraine, Israel, Puerto Rico
-
Metabolic Technologies Inc.National Institute on Aging (NIA); Vanderbilt UniversityCompleted
-
Amsterdam UMC, location VUmcCompletedMultiple SclerosisNetherlands
-
Dana-Farber Cancer InstituteNovartisCompletedMultiple Myeloma in RelapseUnited States
-
Karolinska InstitutetActive, not recruitingMultiple Sclerosis, Relapsing-RemittingSweden
-
Theravance BiopharmaCompletedInflammatory Bowel Diseases | IBDUnited States
-
Karolinska InstitutetMbarara University of Science and Technology; Science for Life Laboratory; Epicentre... and other collaboratorsCompleted
-
Assistance Publique - Hôpitaux de ParisUnknownMultiple Myeloma | Vertebral FractureFrance
-
Parameswaran HariCompletedMultiple MyelomaUnited States
-
University Hospital, Strasbourg, FranceCompleted
-
Eisai Inc.Completed
-
Metabolic Technologies Inc.National Institute on Aging (NIA); Vanderbilt UniversityCompleted
-
Hôpital le VinatierHospices Civils de LyonCompleted
-
Metabolic Technologies Inc.National Institute on Aging (NIA); Vanderbilt UniversityCompleted
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma and other conditionsUnited States
-
National Cancer Institute (NCI)Celgene CorporationTerminated
-
Advocate Health CareCompletedCongenital Heart DiseaseUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Romania, Ukraine, Estonia, Russian Federation, South Africa, Sweden, Netherlands, Slovakia
-
CONRADCompleted
-
TakedaIntra-Cellular Therapies, Inc.TerminatedSchizophreniaUnited States
-
Merck KGaA, Darmstadt, GermanyGesellschaft für Therapieforschung mbHCompleted
-
PfizerCompleted